Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02754726
Recruitment Status : Active, not recruiting
First Posted : April 28, 2016
Last Update Posted : March 3, 2022
Translational Genomics Research Institute
Bristol-Myers Squibb
Lustgarten Foundation
Information provided by (Responsible Party):
HonorHealth Research Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : June 2023